Year 5 Include additional rows as appropriate Section 5: Key Collaborations Patient and Public Involvement (up to 400 words) You must consult with brain tumour patients in the design of this trial through The Charity’s Research Involvement Network. What feedback did you receive and what changes did you make in response? What are your plans for continued PPI in the management, delivery and dissemination of the trial? NCRI Clinical Studies Group (CSG) (up to 200 words) What interaction have you had with the NCRI CSG in relation to this trial? If you have a letter of support from the CSG Chair, please submit it with your application. Clinical Research Networks (up to 200 words) How many Clinical Research Networks will be involved in each of England, Northern Ireland, Scotland and Wales? List the staff time that will be required and the outcome of any discussions with the Cancer Network Leads for the regions involved in the trial. Working with The Brain Tumour Charity during the grant period (up to 200 words) How will you work with The Charity and its supporters to promote its work and the impact of your research over the course of the grant and subsequently? Please note all trial participants must be informed of the option to join The databank BRIAN during the consent process, and trial data Charity’s collection must be in a format enabling straightforward transfer of trial data to the Databank. Pharmaceutical Companies (up to 200 words) Is the CI or CTU in negotiations with any pharmaceutical company about this application? If so, please give details. Section 6: Current funding and publications Current funding For the Principal Applicant and all co-applicants: List all current research funding and funding obtained in the last 5 years. State the name of the funding body, title of project, amounts awarded and start and end dates of support. For current grants, indicate the number of hours per week that are spent on each project.
Year 5 Include additional rows as appropriate Section 5: Key Collaborations Patient and Public Involvement (up to 400 words) You must consult with brain tumour patients in the design of this trial through The Charity’s Research Involvement Network. What feedback did you receive and what changes did you make in response? What are your plans for continued PPI in the management, delivery and dissemination of the trial? NCRI Clinical Studies Group (CSG) (up to 200 words) What interaction have you had with the NCRI CSG in relation to this trial? If you have a letter of support from the CSG Chair, please submit it with your application. Clinical Research Networks (up to 200 words) How many Clinical Research Networks will be involved in each of England, Northern Ireland, Scotland and Wales? List the staff time that will be required and the outcome of any discussions with the Cancer Network Leads for the regions involved in the trial. Working with The Brain Tumour Charity during the grant period (up to 200 words) How will you work with The Charity and its supporters to promote its work and the impact of your research over the course of the grant and subsequently? Please note all trial participants must be informed of the option to join The Charity’s databank BRIAN during the consent process, and trial data collection must be in a format enabling straightforward transfer of trial data to the Databank. Pharmaceutical Companies (up to 200 words) Is the CI or CTU in negotiations with any pharmaceutical company about this application? If so, please give details. Section 6: Current funding and publications Current funding For the Principal Applicant and all co-applicants: List all current research funding and funding obtained in the last 5 years. State the name of the funding body, title of project, amounts awarded and start and end dates of support. For current grants, indicate the number of hours per week that are spent on each project.
glioma_trial_application_form_v4_form_protection.docx